{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:22:45Z","timestamp":1792873365984,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ahj.2009.11.030","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T04:46:51Z","timestamp":1268110011000},"page":"361-369.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)\u2014A randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events"],"prefix":"10.1016","volume":"159","clinical-trial-number":[{"clinical-trial-number":"nct00225849","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Tamio","family":"Teramoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2009.11.030_bib1","author":"The Ministry of Health, Labour and Welfare, Japan"},{"key":"10.1016\/j.ahj.2009.11.030_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2009.11.030_bib3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","volume":"34","author":"Ryan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2009.11.030_bib4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/hc3801.097475","volume":"104","author":"Smith","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.11.030_bib5","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/01.STR.30.11.2502","article-title":"AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association","volume":"30","author":"Albers","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2009.11.030_bib6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2009.11.030_bib7","series-title":"National clinical guidelines for stroke","author":"Royal College of Physicians","year":"2004"},{"issue":"Suppl IV","key":"10.1016\/j.ahj.2009.11.030_bib8","first-page":"1081","article-title":"Guidelines for secondary prevention of myocardial infarction","volume":"64","year":"2000","journal-title":"Jpn Circ J"},{"issue":"Suppl VI","key":"10.1016\/j.ahj.2009.11.030_bib9","first-page":"1123","article-title":"Guidelines for management of acute coronary syndrome without persistent ST-segment elevation (JCS 2002)","volume":"66","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2009.11.030_bib10","series-title":"Japanese guidelines for the management of stroke (2004)","author":"Joint Committee on Guidelines for the Management of Stroke","year":"2004"},{"key":"10.1016\/j.ahj.2009.11.030_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2009.11.030_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2009.11.030_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","author":"The Medical Research Council's General Practice Research Framework","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.11.030_bib14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.11.030_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.11.030_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2009.11.030_bib17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2009.11.030_bib18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2009.11.030_bib19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1253\/circj.71.995","article-title":"Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan: results from domestic baseline data of the REduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"71","author":"Yamazaki","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2009.11.030_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2009.11.030_bib21","author":"World Health Organization"},{"key":"10.1016\/j.ahj.2009.11.030_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08037059209077502","article-title":"Prospective randomized blinded end-point (PROBE) Study: a novel design for intervention trials","volume":"1","author":"Hansson","year":"1992","journal-title":"Blood Press"},{"key":"10.1016\/j.ahj.2009.11.030_bib23","series-title":"Guidelines for the management of hypertension (JSH 2004)","year":"2004"},{"key":"10.1016\/j.ahj.2009.11.030_bib24","series-title":"Japan Atherosclerosis Society (JAS) guidelines for diagnosis and treatment of atherosclerotic cardiovascular diseases 2002","year":"2002"},{"key":"10.1016\/j.ahj.2009.11.030_bib25","series-title":"Evidence-based practice guideline for the treatment of diabetes in Japan","year":"2004"},{"key":"10.1016\/j.ahj.2009.11.030_bib26","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","volume":"108","author":"Luepker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2009.11.030_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5551\/jat.13.202","article-title":"Prevalence of metabolic syndrome in the general Japanese population in 2000","volume":"13","author":"Arai","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ahj.2009.11.030_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjmed.2004.04.017","article-title":"Application of U.S. Guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan","volume":"117","author":"Morimoto","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2009.11.030_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1291\/hypres.27.755","article-title":"Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) Study","volume":"27","author":"Ohkubo","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ahj.2009.11.030_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.curtheres.2005.04.004","article-title":"Status of lipid-lowering therapy prescribed based on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults; a study of the Japan Lipid Assessment Program (J-LAP)","volume":"66","author":"Teramoto","year":"2005","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.ahj.2009.11.030_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2169\/internalmedicine.45.1609","article-title":"Outcome of one-year of specialist care of patients with type 2 diabetes: a multi-center prospective survey (JDDM 2)","volume":"45","author":"Sone","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.ahj.2009.11.030_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.thromres.2006.12.010","article-title":"Gastroduodenal mucosal injury in patients on antiplatelet therapy","volume":"120","author":"Yamamoto","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.ahj.2009.11.030_bib33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal hemorrhage with long-term use of aspirin: meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309009557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309009557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:40:04Z","timestamp":1757569204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870309009557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0002870309009557"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2009.11.030","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)\u2014A randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2009.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}